The host-immune response in hospitalized COVID-19 patients in different metabolic interventions.
INFLAMMATION, DISEASE PROGRESSION
(Reports suggest that severe COVID-19 is characterized by early inflammation, marked by elevated C-reactive protein (CRP) To track disease progression, we followed changes in CRP during the first 21 days of hospitalization. Data were fitted using locally weighted scatterplot smoothing (Lowess) comparing each drug group to all other high-risk patients that did not take metabolic regulators (n=648; Analysis of an additional observational cohort of 2123 patients examined in the Outpatient Lipid Clinics of the University of Bologna and the Niguarda Hospital in Milan during the last 12 months and on adequately dosed statins, fenofibrate, or both for at least 3 months (